KemPharm Inc

PROVEN MEDICINES ... SAFER THERAPIES

News/events

Press Releases

2013

4/16/2013		KemPharm Advances KP201 Clinical and Commercial Program with Completion of Tablet Registration Activities
4/3/2013		KemPharm, Inc Receives Notice of Allowance for Novel Pain Drug Candidate, KP201
2/14/2013		KemPharm Supports Recent FDA Recommendations for Hydrocodone-Containing Compounds and Abuse-Deterrent Opioids
1/7/2013		KemPharm, Inc Receives USAN Approval for Nonproprietary Name of Novel Pain Drug Candidate, KP201
1/2/2013		KemPharm, Inc. to Present at Biotech Showcase™ 2013

2012

2011

2010

2009

News and Media

Video		Bloomberg TV: #1 Cause of Accidental Death in U.S.: Painkillers (click to expand for video)

5/6/2013		Unmeltable, Uncrushable: The Holy Grail in Painkillers (may require subscription to The Wall Street Journal)
4/16/2013		FDA approves abuse-deterrent labeling for reformulated OxyContin
1/9/2013		FDA issues draft guidance on abuse-deterrent opioids

Recent/Upcoming Events

April 22-25, 2013		2013 BIO International Convention - Chicago, IL
May 8-11, 2013		American Pain Society - 32nd Annual Scientific Meeting - New Orleans, LA
June 9-11, 2013		International Conference on Opioids - Boston, MA